Faster access to new medicines and fewer shortages a 'major step forward'

A key issue is reducing how long public patients wait for new medicines to be assessed compared to private patients. 

Patients could see faster access to new medicines, fewer shortages, and more access to generic medicines under deals agreed between the Government, HSE, and pharmaceutical industry on Tuesday.

The agreements cover pricing and supply for public health services until December 2029.